Загрузка...
Changes in B and T lymphocytes and chemokines with rituximab treatment in multiple sclerosis
BACKGROUND: B cells are implicated in the pathogenesis of multiple sclerosis (MS). A beneficial effect of B cell depletion using rituximab has been shown, but the complete mechanism of action for this drug is unclear. OBJECTIVE: To determine the relationship between T cells, B cells, and changes in...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2918395/ https://ncbi.nlm.nih.gov/pubmed/20558389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.99 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|